A Multinational, Open Label, Randomised, Three Period, Cross Over Trial Investigating The Impact Of Exercise And Type Of Basal Insulin Used On Blood Glucose Levels In Subjects With Type 1 Diabetes Treated With a Basal Bolus Regimen Using Insulin Detemir, Glargine and NPH as Comparators and Insulin Aspart as Bolus Insulin Levemir Exercise Study

Trial Profile

A Multinational, Open Label, Randomised, Three Period, Cross Over Trial Investigating The Impact Of Exercise And Type Of Basal Insulin Used On Blood Glucose Levels In Subjects With Type 1 Diabetes Treated With a Basal Bolus Regimen Using Insulin Detemir, Glargine and NPH as Comparators and Insulin Aspart as Bolus Insulin Levemir Exercise Study

Completed
Phase of Trial: Phase IV

Latest Information Update: 18 Dec 2014

At a glance

  • Drugs Insulin detemir (Primary) ; Insulin aspart; Insulin glargine; Insulin suspension isophane
  • Indications Type 1 diabetes mellitus
  • Focus Therapeutic Use
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 07 Jul 2009 Actual patient number (51) added as reported by ClinicalTrials.gov.
    • 07 Jul 2009 Actual initiation date changed from Mar 2006 to Apr 2006 as reported by ClinicalTrials.gov.
    • 07 Jul 2009 Actual end date (Nov 2006) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top